Graphite Has Surged 250%
Source: Nick Hodge, Energy & Capital  (4/12/12)
"Now is the time to take advantage of the graphite bull. Prices for the mineral have surged 250% in the past few years thanks to a number of factors." More >

Gold Equities Gaining Credibility: Doug Groh
Source: Brian Sylvester of The Gold Report   (4/11/12)
While gold equities continue to trail the gold price, junior stocks are gaining traction according to Doug Groh, co-portfolio manager and senior analyst with Tocqueville Asset Management. He believes investors should not let the market's risk aversion keep them out of a stock picker's market. The trick, Groh reveals in this exclusive Gold Report interview, is to pick managements, not jurisdictions. More >

Gold Steadies as Italy, Spain Face Higher Borrowing Costs
Source: Ben Traynor, BullionVault  (4/11/12)
"Gold hovered near $1,600/oz as European stock markets recovered some ground following yesterday's losses." More >

Can Russia and China Break the Gas Supply Price Deadlock?
Source: Stuart Elliott and John Roberts, Platts  (4/11/12)
"Chinese natural gas demand is expected to continue to strengthen in the next decade, and part of its needs could still be met by Russian imports despite the continued deadlock over a pricing policy." More >

The Keystone Pipeline Fallout: Canada Makes Over a Billion New Friends
Source: James Baldwin, Money Morning  (4/11/12)
"You can forget about energy independence for now. Without Canadian oil, it is nothing but an American pipe dream. In the wake of the Keystone pipeline decision, Canada has decided to play ball with China instead." More >

Sell in May and Go Away?
Source: Keith Schaefer, Oil & Gas Investments  (4/11/12)
"Market action in 2012 is saying strongly that would be the wrong track for investors." More >

Investing in Graphite's Growth: Kevin Puil
Source: Brian Sylvester of The Critical Metals Report  (4/10/12)
As the boundaries of technology continually expand, so does the demand for graphite. With uses developing and supply mainly controlled by China, prices for graphite should continue to climb, says Kevin Puil, senior analyst for the Encompass Fund and portfolio manager with San Francisco-based Malcolm H. Gissen & Associates. In this exclusive interview with The Critical Metals Report, Puil shares some junior miners set to soar alongside demand. More >

Sweet Spots in a Patchy Oil Price Landscape: Frank Saldana
Source: Zig Lambo of The Energy Report  (4/10/12)
A variety of geopolitical, economic, technical, regulatory and transportation factors are having some confusing effects on U.S. prices for oil, natural gas and gas by-products. In this exclusive interview with The Energy Report, Frank Saldana, senior E&P energy analyst at C. K. Cooper & Company, explains how these various factors impact the domestic producers of oil and gas products and talks about several attractive investment opportunities in the current market environment. More >

For Gold to Rise, Physical Buyers Must Return
Source: Geoff Candy, Mineweb  (4/10/12)
"Despite weaker-than-expected U.S. jobs numbers out last week and renewed hopes of QE3, analysts say that the physical market needs to return if gold is to start re-gathering momentum." More >

Managing Expectations: Why Gold Should Thrive
Source: Frank Holmes, U.S. Global Investors  (4/10/12)
"Investing, like life, is about managing expectations: Even throughout gold's decade-long rise, price action over the short term can go both ways." More >

A Return to the Gold Standard, or Gold Behind Currencies, Part 1
Source: Julian Phillips, Gold Forecaster  (4/10/12)
"The concept of quantitative easing is similar to devaluing the dollar against gold, but taking worthless assets that banks depended on for backing their credit and replacing them with freshly printed ones." More >

Weight Loss Stocks Race to End the Obesity Epidemic
Source: Diane Alter, Money Morning  (4/10/12)
"The economic burden of obesity is estimated to be 10% of total health care costs, with projections continuing to grow as the obesity epidemic spreads. For investors, that means weight loss stocks are poised to gain." More >

Breaking the Mold of Oncology Drug Development
Source: Seeking Alpha, Brian Nichols  (4/10/12)
"Looking at all oncology products on the market, it is striking to note how each targets a single factor in the complex processes that control tumor growth and invasion. It is almost like attempting to stop traffic in a city by blocking a single avenue: It only slows down traffic but doesn't stop it completely." More >

On Estimating Rare Earth Reserves
Source: Gareth Hatch, Resource Investor  (4/10/12)
"The NI 43-101 approach to mineral-resource classification provides greater transparency on the early stages of project development with a rigorous reporting framework that is missing under the SEC guidelines." More >

Fatty Acids Fight Cancer Spread
Source: News Medical  (4/9/12)
"Tiny agents found in omega-3 could potentially be used to block the path of primary cancer tumors, preventing the advance to secondary-stage cancers." More >

Gold Stocks: Timing Your Next Purchase
Source: Bob Kirtley, SK Options Trading  (4/9/12)
"For now, we will hold fast and continue to look for absolute bargains. Try to be patient enough to wait for the real deal." More >

Failed Bottom in Gold Stocks Initiates Start of Capitulation
Source: Jordan Roy-Byrne, The Daily Gold  (4/9/12)
"It is more than obvious that the market is likely to make a V bottom. The good news is the market likely will be substantially higher six months and one year after the low." More >

Stocks Have Reached the Euphoria Stage
Source: Toby Connor, Gold Scents  (4/9/12)
"My best guess is that we will see a sharp selloff over the next two to three weeks, followed by a sharp rebound (QE3?) that may or may not move stocks to marginal new highs." More >

Gold Prices Are Set for Further Decline
Source: J.W. Jones, Options Trading Signals  (4/9/12)
"The real question has become when and where will the dollar top? When the dollar tops and gold finds a major bottom, the potential for a monster move higher will become likely." More >

Never Mistake Intelligence for a Bull Market: George Ireland
Source: Brian Sylvester of The Gold Report   (4/9/12)
George Ireland, portfolio manager with Boston-based Geologic Resource Partners, believes in seeing what he invests in and his passport bears witness: 80 countries visited in five years. From Africa to Argentina, from gold to lithium and graphite, he and his team seek out companies with experienced management, promising geology, good infrastructure and strong cash flow. Ireland shares his views on issues facing the mining industry in all corners of the world in this exclusive Gold Report interview. More >

Coal Stocks Are Historically Cheap—Here's What You Need to Know
Source: Patrick Vail, Money Morning  (4/9/12)
"With a torrent of factors dragging the industry down, can coal make a comeback? Let's look at what's the matter with coal, why it doesn't matter in the big picture, and how you can make some money on the rebound." More >

Why You Should Invest In Natural Gas
Source: Jared Cummans, ETF Daily News  (4/9/12)
"Companies and funds that focus on natural gas producers and extractors stand to gain a fair amount of ground in coming years as pipelines and productions skyrocket." More >

Nanotechnology Used to Hunt for Hidden Pathogens
Source: ScienceDaily  (4/9/12)
"The new nanoparticle-based technique may be used to detect microbes that have challenged scientists for centuries because they hide deep in human tissue and are able to reprogram cells to successfully evade the immune system." More >

Biotech Stocks: How to Invest in the Buyout Binge
Source: William Patalon, Money Morning  (4/9/12)
"The very same problem that has big pharma execs wringing their hands is also creating one of the biggest profit opportunities we've seen in years." More >

Studies Suggest that When It Comes to Drug Development Success, Size Matters
Source: Alex Philippidis, Genetic Engineering & Biotechnology News  (4/9/12)
"Studies have come to the conclusion that biologics hold better prospects than traditional small molecules of advancing all the way from the lab to the clinic to the market." More >